Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. by Bhaskaran, K, Mussini, C, Antinori, A, Walker, A, Dorrucci, M, Sabin, C, Phillips, A, Porter, K

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort stu... by Wolbers, M, Babiker, A, Sabin, C, Young, J, Dorrucci, M, Chêne, G, Mussini, C, Porter, K, Bucher, H

Safety and efficacy of the Russian COVID-19 vaccine: more information needed by Bucci, E, Andreev, K, Björkman, A, Calogero, RA, Carafoli, E, Carninci, P, Castagnoli, P, Cossarizza, A, Mussini, C, Guerin, P, Lipworth, B, Sbardella, G, Stocki, T, Tuosto, L, van Tulleken, C, Viola, A

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. by Ledergerber, B, Lundgren, J, Walker, A, Sabin, C, Justice, A, Reiss, P, Mussini, C, Wit, F, d'Arminio Monforte, A, Weber, R, Fusco, G, Staszewski, S, Law, M, Hogg, R, Lampe, F, Gill, M, Castelli, F, Phillips, A

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort by d'Arminio Monforte, A, Cozzi-Lepri, A, Ceccherini-Silberstein, F, De Luca, A, Lo Caputo, S, Castagna, A, Mussini, C, Cingolani, A, Tavelli, A, Shanyinde, M, Gori, A, Girardi, E, Andreoni, M, Antinori, A, Puoti, M, on behalf of Icona Foundation And Hepaicona Study Group

International healthcare workers’ experiences and perceptions of the 2022 multi-country mpox outbreak by Apea, V, Titanji, BK, Dakin, FH, Hayes, R, Smuk, M, Kawu, H, Waters, L, Levy, I, Kuritzkes, DR, Gandhi, M, Rockstroh, J, Schechter, M, Holt, M, Palich, R, Cortes, CP, Nozza, S, Mussini, C, Calmy, A, Crabtree-Ramirez, BE, Blanco, JL, Bhagani, S, Dewsnap, C, Orkin, C, On Behalf of the Mpox SHARE-NET Writing Group

Common genetic variation and the control of HIV-1 in humans. by Fellay, J, Ge, D, Shianna, K, Colombo, S, Ledergerber, B, Cirulli, E, Urban, T, Zhang, K, Gumbs, C, Smith, J, Castagna, A, Cozzi-Lepri, A, De Luca, A, Easterbrook, P, Günthard, H, Mallal, S, Mussini, C, Dalmau, J, Martinez-Picado, J, Miro, J, Obel, N, Wolinsky, S, Martinson, J, Detels, R, Margolick, J, Jacobson, L, Descombes, P, Antonarakis, SE, Beckmann, J, O'Brien, S, Letvin, N, Mcmichael, A, Haynes, B, Carrington, M, Feng, S, Telenti, A, Goldstein, D

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study by Gregson, J, Tang, M, Ndembi, N, Hamers, R, Marconi, V, Brooks, K, Theys, K, Arruda, M, Garcia, F, Monge, S, Kanki, P, Kumarasamy, N, Kerschberger, B, Mor, O, Charpentier, C, Todesco, E, Rokx, C, Gras, L, Halvas, E, Sunpath, H, Carlo, D, Antinori, A, Andreoni, M, Latini, A, Mussini, C, Aghokeng, A, Sonnerborg, A, Neogi, U, Fessel, W, Agolory, S, Yang, C, Blanco, J, Juma, J, Smit, E, Schmidt, D, Watera, C, Asio, J, Kirungi, W, Tostevin, A, Clumeck, N, Goedhals, D, Bester, P, Sabin, C, Mukui, I, Santoro, M, Perno, C, Hunt, G, Morris, L, Camacho, R, Pillay, D, Schulter, E, Reyes-Terán, G, Romero, K, Avila-Rios, S, Sirivichayakul, S, Ruxrungtham, K, Mekprasan, S, Dunn, D, Kaleebu, P, Raizes, E, Kantor, R, Shafer, R, Gupta, R, Rhee, S, De Wit, T, Diero, L, Günthard, H, Hoffmann, C, Di Carlo, D